Stem Holdings, Inc. (STMH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Stem Holdings, Inc. (STMH) trades at $0.00001. Stem Holdings, Inc. is a vertically-integrated cannabis company involved in the production, distribution, and sale of cannabis and cannabis-infused products. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for STMH: STMH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates STMH against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on STMH.
How is this calculated? →Stem Holdings, Inc. (STMH) Healthcare & Pipeline Overview
Stem Holdings, Inc. is a vertically-integrated cannabis company focused on production, distribution, and technology within the cannabis sector. With a portfolio of cannabis and CBD brands, Stem Holdings operates in a competitive market, navigating regulations and aiming to expand its market share through strategic licensing and e-commerce platforms.
What Is the Investment Thesis for STMH?
Stem Holdings operates in the rapidly expanding cannabis industry, presenting both opportunities and risks. The company's vertically-integrated structure, encompassing cultivation, processing, distribution, and retail, allows for greater control over the supply chain and potentially higher margins. However, the company's market capitalization is $0.00B, and the P/E ratio is -0.00, indicating it's not currently profitable. A key growth catalyst is the potential expansion into new states and the acquisition of additional licenses. Investors should monitor the company's ability to achieve profitability, manage regulatory compliance, and effectively compete with larger players in the cannabis market. The company's success depends on navigating the evolving regulatory landscape and capitalizing on the increasing acceptance of cannabis.
Based on FMP financials and quantitative analysis
STMH Key Highlights
Vertically-integrated operations provide control over the entire cannabis value chain, from cultivation to retail.
- Portfolio of cannabis and CBD brands caters to diverse consumer preferences.
- Ownership interests in 29 state-issued cannabis licenses as of September 30, 2021, enabling multi-state operations.
- Operates Budee and Ganjarunner e-commerce platforms for delivery-as-a-service.
- Market Cap of $0.00B reflects its current valuation in the market.
Who Are STMH's Competitors?
STMH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NGMC Next Generation Management Corp. | $1.00 | -2.91% | 46 | |
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are STMH's Key Strengths?
Vertically-integrated operations.
- Diverse brand portfolio.
- Extensive licensing portfolio.
- E-commerce platforms for delivery services.
What Are STMH's Weaknesses?
Negative P/E ratio indicates lack of profitability.
- Small market capitalization.
- Dependence on regulatory approvals.
- Intense competition in the cannabis industry.
What Could Drive STMH Stock Higher?
Potential legalization of cannabis in additional states could expand market opportunities.
- Expansion of the company's e-commerce platforms to new geographic areas.
- Development and launch of new cannabis-infused products.
- Strategic acquisitions and partnerships with other companies in the cannabis industry.
What Are the Key Risks for STMH?
Financial-distress signal — its Altman Z-Score of -17.10 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Changing regulatory landscape could negatively impact operations.
- Increased competition from larger players could erode market share.
- Price volatility in the cannabis market could impact revenue and profitability.
- Potential for federal legalization to disrupt state-level markets.
- Limited financial disclosure due to OTC listing increases investment risk.
What Are the Growth Opportunities for STMH?
- Expansion into New Geographic Markets: Stem Holdings can pursue growth by expanding its operations into new states that are legalizing cannabis. This involves securing licenses, establishing cultivation and processing facilities, and building out distribution networks. The timeline for expansion depends on the regulatory approval process in each state, but strategic partnerships and acquisitions can accelerate entry.
- Increased Focus on E-commerce and Delivery: With the growing popularity of online shopping, Stem Holdings can further invest in its Budee and Ganjarunner e-commerce platforms to capture a larger share of the delivery market. Enhancing the user experience, expanding delivery coverage, and offering exclusive online promotions can drive customer acquisition and loyalty. The online cannabis market is experiencing rapid growth, and Stem Holdings is well-positioned to capitalize on this trend.
- Development of New Cannabis-Infused Products: Stem Holdings can drive growth by developing and launching new cannabis-infused products that cater to evolving consumer preferences. This includes exploring new formulations, delivery methods, and product categories, such as edibles, beverages, and topicals. Innovation in product development can attract new customers and increase brand loyalty. The market for cannabis-infused products is expanding rapidly, driven by changing consumer tastes and preferences.
- Strategic Acquisitions and Partnerships: Stem Holdings can pursue growth through strategic acquisitions and partnerships with other companies in the cannabis industry. This can provide access to new markets, technologies, and product lines. Acquisitions can also help to consolidate the market and increase market share. The cannabis industry is undergoing consolidation, and Stem Holdings can play a role in this process by acquiring complementary businesses.
- Expansion of CBD Product Line: Stem Holdings can expand its Doseology CBD product line to capitalize on the growing demand for CBD products. This includes developing new CBD formulations, expanding distribution channels, and increasing marketing efforts. The CBD market is experiencing rapid growth, driven by increasing awareness of the potential health benefits of CBD. Stem Holdings is well-positioned to capitalize on this trend with its Doseology brand.
What Are STMH's Competitive Advantages?
- Vertically-integrated operations provide cost advantages and control over the supply chain.
- Brand portfolio creates customer loyalty and differentiation.
- Extensive licensing portfolio provides a barrier to entry.
- E-commerce platforms provide a competitive advantage in the delivery market.
What Does STMH Do?
Stem Holdings, Inc., incorporated in 2016 and headquartered in Boca Raton, Florida, operates as a vertically-integrated cannabis products and technology company. The company's business encompasses the entire value chain, from cultivation and processing to wholesale distribution and retail sales of cannabis and cannabis-infused products. Stem Holdings has developed a portfolio of brands catering to different consumer segments, including TJ's Gardens, TravisxJames, and Yerba Buena for flower and extracts, Cannavore for edible confections, and Doseology for mass-market CBD products. The company also operates delivery-as-a-service brands, Budee and Ganjarunner, which are e-commerce platforms designed to facilitate online cannabis sales and delivery. As of September 30, 2021, Stem Holdings held ownership interests in 29 state-issued cannabis licenses, including licenses for cultivation, processing, wholesale distribution, hemp production, dispensary operations, and adult-use medical retailers. This extensive licensing portfolio enables the company to operate across multiple states and expand its market reach. Stem Holdings aims to leverage its vertically-integrated model and brand portfolio to capture a significant share of the growing cannabis market.
What Products and Services Does STMH Offer?
- Cultivates cannabis plants.
- Processes cannabis into various forms, including flower, extracts, and concentrates.
- Manufactures cannabis-infused products, such as edibles and topicals.
- Distributes cannabis products to dispensaries and retailers.
- Operates retail dispensaries.
- Provides delivery services through its Budee and Ganjarunner e-commerce platforms.
How Does STMH Make Money?
- Vertically-integrated operations generate revenue from cultivation, processing, distribution, and retail sales.
- Brand portfolio generates revenue through the sale of cannabis and CBD products.
- E-commerce platforms generate revenue through delivery fees and product sales.
- Licensing agreements generate revenue through royalties and fees.
What Industry Does STMH Operate In?
Stem Holdings operates within the rapidly evolving cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance of cannabis for both medical and recreational use. The market is characterized by intense competition, with numerous companies vying for market share. Key trends include the consolidation of smaller players, the rise of branded products, and the increasing importance of e-commerce and delivery services. Stem Holdings' vertically-integrated model and diverse brand portfolio position it to capitalize on these trends, but it faces challenges from larger, more established companies and the complex regulatory landscape.
Who Are STMH's Key Customers?
- Adult-use cannabis consumers.
- Medical cannabis patients.
- Retail dispensaries.
- Wholesale distributors.
Company Profile
Stem Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Boca Raton, US. The company is led by CEO Matthew J. Cohen. STMH has traded publicly since 2021.
Financial Health
Stem Holdings, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -17.10 places it in the distress zone, a signal of elevated financial risk.
Forward Outlook
Wall Street analysts project Stem Holdings, Inc. revenue of about $39.6M for fiscal 2026, with EPS near $-11.00.
Insider Activity
The most recent 11 insider filings for Stem Holdings, Inc. break down as 1 sales and 10 purchases. On net that is roughly 19.0M shares acquired (about $426K) — insiders putting money in tends to read as conviction.
STMH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Vertically-integrated operations.
- Diverse brand portfolio.
- Extensive licensing portfolio.
- E-commerce platforms for delivery services.
Bear Case
- Negative P/E ratio indicates lack of profitability.
- Small market capitalization.
- Dependence on regulatory approvals.
- Intense competition in the cannabis industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
STMH Latest News
No recent news available for STMH.
STMH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for STMH.
Price Targets
Wall Street price target analysis for STMH.
STMH MoonshotScore
What does this score mean?
The MoonshotScore rates STMH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Matthew J. Cohen
CEO
Matthew J. Cohen serves as the CEO of Stem Holdings, Inc. His background includes experience in managing teams and overseeing the operations of the company. Information regarding his previous roles and educational background is not available. As CEO, he is responsible for the overall strategic direction and performance of Stem Holdings, including overseeing its vertically-integrated operations and managing its portfolio of cannabis and CBD brands.
Track Record: Under Matthew J. Cohen's leadership, Stem Holdings has focused on expanding its operations and building its brand portfolio. Key milestones include the acquisition of additional cannabis licenses and the development of its Budee and Ganjarunner e-commerce platforms. However, the company has yet to achieve profitability, and its market capitalization remains relatively small.
STMH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Stem Holdings may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, and trading activity can be sporadic. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and the potential for fraud or manipulation. These companies often do not file with the SEC.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Low liquidity can lead to price volatility and difficulty in trading shares.
- Higher risk of fraud or manipulation due to lack of regulatory oversight.
- Potential for delisting or suspension of trading.
- Limited access to capital and financing options.
- Verify the company's registration and licensing status.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Evaluate the company's business model and competitive landscape.
- Analyze the company's capital structure and debt levels.
- Monitor trading activity and price movements.
- Consult with a qualified financial advisor.
- Ownership interests in state-issued cannabis licenses.
- Operation of e-commerce platforms for delivery services.
- Presence of a management team.
- Existence of a portfolio of cannabis and CBD brands.
Common Questions About STMH (Healthcare)
What does Stem Holdings, Inc. do?
Stem Holdings, Inc. operates as a vertically-integrated cannabis company, meaning it is involved in multiple stages of the cannabis value chain, from cultivation and processing to distribution and retail sales. The company produces and sells a variety of cannabis and CBD products under its brand portfolio, including flower, extracts, edibles, and topicals. Stem Holdings also operates e-commerce platforms for delivery services, connecting consumers with cannabis products.
What are the main risks for STMH?
The main risks for Stem Holdings include the evolving regulatory landscape, increased competition, price volatility in the cannabis market, and the potential for federal legalization to disrupt state-level markets. As an OTC-listed company, Stem Holdings also faces risks related to limited financial disclosure and liquidity. Investors should carefully consider these risks before investing in STMH. The company's ability to navigate these challenges will determine its long-term success.
What are the key factors to evaluate for STMH?
Evaluate STMH on fundamentals, analyst consensus, and risk factors. Stem Holdings operates in the rapidly expanding cannabis industry, presenting both opportunities and risks. Not financial advice.
How frequently does STMH data refresh on this page?
STMH's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven STMH's recent stock price performance?
Stem Holdings, Inc. (STMH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically-integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider STMH overvalued or undervalued right now?
Stem Holdings, Inc. (STMH) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research STMH before investing?
Before investing in Stem Holdings, Inc. (STMH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding STMH to a portfolio?
Key strength of Stem Holdings, Inc. (STMH): Vertically-integrated operations. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of 2026-03-17.
- AI analysis is pending for STMH.
- OTC market investments carry significant risk.